Challenges in Drug Development

Considerable challenges in drug development, particularly in the face of further organizational changes slated for OGD. A range of legislative and regulatory actions have facilitated consumer access to safe, high-quality generic products, although manufacturing lapses and product quality problems have created critical shortages in important medicines, casting a shadow over the industry's success.

In 2012 the global market for drug development and services reached $3.5 billion. This market is reached $4.5 billion in 2013 and expected to reach 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.

  • Phase zero trials
  • Mechanism
  • Drug delivery essentials towards better bioavailability

Related Conference of Challenges in Drug Development

June 06-07, 2018

International Conference & B2B on Pharma Research and Development

Philadelphia, Pennsylvania, USA
June 27-28, 2018

4thInternational Conference on Drug Discovery, Designing Chemistry and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 15-16, 2018

14th International Conference on Generic Drugs and Biosimilars

Frankfurt, Germany
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Challenges in Drug Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in